Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
      • All Events
      • COVID-19
      • Diabetes
      • Immunology
      • Neuroscience
      • Oncology
      • Cardiovascular
      • COVID-19
      • Diabetes
      • Immunology
      • Men's Health
      • Neuroscience
      • Oncology
  • Medical Education
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the LillyMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.com.

  1. Medical Information Right
  2. Diabetes Right
  3. Baqsimi (glucagon) nasal powder Right
  4. What is the frequency of severe hypoglycemia in people with type 1 diabetes?
Search Baqsimi (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Baqsimi ® (glucagon) nasal powder

3mg

Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

What is the frequency of severe hypoglycemia in people with type 1 diabetes?

The mean incidence of severe hypoglycemia events in people with type 1 diabetes using insulin was approximately 1.5 events/person/year.

US_cFAQ_NG801_SEVERE_HYPO_FREQUENCY_T1D
US_cFAQ_NG801_SEVERE_HYPO_FREQUENCY_T1D
en-US

Hypoglycemic Events

Hypoglycemia Events in People With Type 1 Diabetes Mellitus

Frier et al published a review that evaluated various published cohorts of people with type 1 diabetes and the frequency of severe hypoglycemia.1

This review included 10 published studies in people with type 1 diabetes mellitus (T1DM) that

  • were both prospective and retrospective in design
  • evaluated between 100 and 3813 people
  • were older than 14 years of age
  • had a duration of follow-up between 1 week and 19 months
  • had reported mean glycated hemoglobin values of 7.3% to 10.7%
  • had severe hypoglycemia defined as the need for third party assistance or glucagon/intravenous glucose, and
  • had various insulin regimens with the majority ranging from twice daily injections to 4 or more injections daily or continuous subcutaneous insulin infusion.1

Using data from a variety of published cohorts summarized in the review by Frier et al, the mean incidence of severe hypoglycemia events in people with T1DM using insulin was approximately 1.5 events/person/year (range, 0.2-3.2 events/person/year).1

Using data from a variety of published cohorts summarized in the review by Frier et al, the prevalence of severe hypoglycemia events in people with T1DM using insulin was approximately 29% (range, 3%-46%).1

Enclosed Prescribing Information

BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly

Reference

The published reference below is available by contacting 1-800-LillyRx (1-800-545-5979).

1Frier BM. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nat Rev Endocrinol. 2014;10(12):711-722. http://dx.doi.org/10.1038/nrendo.2014.170

Date of Last Review: October 06, 2021

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.4 08/2022 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2022. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    Facebook Twitter
    visit www.phactmi.org
    Lilly